|
CD46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14990000749304E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.75440001099525E-09 |
| Normal-vs-Stage2 |
2.05920000051485E-07 |
| Normal-vs-Stage3 |
3.69060000005028E-06 |
| Normal-vs-Stage4 |
1.59778999999638E-05 |
| Stage1-vs-Stage2 |
8.668000E-01 |
| Stage1-vs-Stage3 |
5.797600E-01 |
| Stage1-vs-Stage4 |
7.203200E-01 |
| Stage2-vs-Stage3 |
5.368600E-01 |
| Stage2-vs-Stage4 |
7.239200E-01 |
| Stage3-vs-Stage4 |
4.391200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42070000208605E-09 |
| Normal-vs-AfricanAmerican |
5.66820000047485E-07 |
| Normal-vs-Asian |
3.979100E-04 |
| Caucasian-vs-AfricanAmerican |
5.887200E-01 |
| Caucasian-vs-Asian |
7.441000E-01 |
| AfricanAmerican-vs-Asian |
6.113400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10520481655385E-11 |
| Normal-vs-Female |
5.70300000000135E-05 |
| Male-vs-Female |
1.264000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.98620000005467E-06 |
| Normal-vs-Extreme_Weight |
4.46079950755518E-10 |
| Normal-vs-Obese |
5.49259999704788E-08 |
| Normal-vs-Extreme_Obese |
8.34880000000204E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.788400E-01 |
| Normal_Weight-vs-Obese |
9.892800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.763200E-01 |
| Extreme_Weight-vs-Obese |
1.884160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.742000E-01 |
| Obese-vs-Extreme_Obese |
5.981800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.404000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.16470000036217E-07 |
| Normal-vs-Age(61-80Yrs) |
2.75189981913115E-10 |
| Normal-vs-Age(81-100Yrs) |
7.47499999675938E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.300200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.571570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.605600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.015500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.910100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.251000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.31490041077598E-10 |
| Normal-VS-Type2 PRCC |
1.97700000814649E-09 |
| Normal-VS-KIRP CIMP |
2.357900E-02 |
| Normal-VS-Unclassified PRCC |
2.07309999999961E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.570000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.478800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.852800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.397430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.427800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.532200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83026943495679E-14 |
| Normal-vs-N1 |
1.459510E-03 |
| Normal-vs-N2 |
1.191940E-02 |
| N0-vs-N1 |
3.513900E-02 |
| N0-vs-N2 |
3.798000E-01 |
| N1-vs-N2 |
6.645200E-01 |
|
|
